advanced nsclc

Showing 1 - 13 of 13

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Advanced NSCLC Trial in China (Gene Profile explore)

Recruiting
  • Advanced NSCLC
  • Gene Profile explore
  • Beijing, China
  • +14 more
Jan 27, 2023

Advanced NSCLC, Metastatic Lung Cancer Trial in East Syracuse, Cleveland, Bellingham (Adagrasib in combination with

Recruiting
  • Advanced NSCLC
  • Metastatic Lung Cancer
  • Adagrasib in combination with pembrolizumab
  • Pembrolizumab
  • East Syracuse, New York
  • +2 more
Nov 28, 2022

Advanced NSCLC Trial in United States (REGN5093-M114)

Recruiting
  • Advanced NSCLC
  • Aurora, Colorado
  • +7 more
Aug 11, 2022

Advanced NSCLC Trial in Yangzhou (camrelizumab + famitinib, famitinib, docetaxel)

Recruiting
  • Advanced NSCLC
  • camrelizumab + famitinib
  • +2 more
  • Yangzhou, Jiangsu, China
    Subei People's Hospital of Jiangsu Province
Jan 11, 2022

Advanced NSCLC Trial (CT053PTSA)

Not yet recruiting
  • Advanced NSCLC
  • (no location specified)
Jul 29, 2021

Advanced NSCLC Trial in La Jolla (Nivolumab, Oxaliplatin, Ipilimumab)

Recruiting
  • Advanced NSCLC
  • La Jolla, California
    UC San Diego Moores Cancer Center
Apr 1, 2021

Circulating Tumor Cells Gene Mutation Detection From Advanced

Unknown status
  • Advanced NSCLC
  • +2 more
  • nonintervention
  • (no location specified)
Jan 10, 2020

Advanced NSCLC Trial in Beijing (Alflutinib)

Unknown status
  • Advanced NSCLC
  • Beijing, China
    cancer hospital Chinese academy of medical sciences
Jan 2, 2020

Advanced Nsclc Trial in Jinan (Thalidomide, pemetrexed, cisplatin)

Unknown status
  • Advanced Nsclc
  • Jinan, Shandong, China
    Qilu hospital of Shandong University
Jun 3, 2019

Advanced NSCLC, First Line Treatment Trial in Heidelberg (Exercise Intervention, Care-Management-Phone-Calls)

Completed
  • Advanced NSCLC
  • First Line Treatment
  • Exercise Intervention
  • Care-Management-Phone-Calls
  • Heidelberg, Baden-Württemberg, Germany
    Thoracic Oncology Clinic for Thoracic Diseases
Aug 22, 2018

Advanced Nsclc Trial in Chongqing (radiotherapy)

Unknown status
  • Advanced Nsclc
  • radiotherapy
  • Chongqing, China
    Xinqiao Hospital of Chongqing
Mar 7, 2017

Advanced NSCLC, Recurrent NSCLC Trial in Tianjin (Endostar(rh recombinant endostatin) plus Docetaxel, Placebo plus Docetaxel)

Unknown status
  • Advanced NSCLC
  • Recurrent NSCLC
  • Endostar(rh recombinant endostatin) plus Docetaxel
  • Placebo plus Docetaxel
  • Tianjin, China
    Cancer Hospital of Tianjin Medical University
Jan 22, 2010